Role of human epidermal growth factor receptor 2 in gastric cancer: Biological and pharmacological aspects

doi:10.3748/wjg.v20.i16.4526

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 20, Issue 16

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (11108)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-6) series, Tables (1-3) series.

Item

Count

PDF

578

WORD

349

HTML

7756

Figures (1-6)

157

Tables (1-3)

128

Sum=8968

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1205

Download

935

Sum=2140

Apr 28, 2014 (publication date) through Apr 22, 2024

Times Cited of This Article

Times Cited (31)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Topic Highlight

World J Gastroenterol. Apr 28, 2014; 20(16): 4526-4535
Published online Apr 28, 2014. doi: 10.3748/wjg.v20.i16.4526

Full Size Figure Download Figure

Figure 3 Human epidermal growth factor receptor 2 testing algorithm developed based on the results of the ToGA trial. Immunohistochemistry (IHC) is the primary test with reflex testing with Fluorescence in situ hybridization (FISH) in case of an equivocal IHC result (IHC2+)[27].

Citation: Jørgensen JT. Role of human epidermal growth factor receptor 2 in gastric cancer: Biological and pharmacological aspects. World J Gastroenterol 2014; 20(16): 4526-4535
URL: https://www.wjgnet.com/1007-9327/full/v20/i16/4526.htm
DOI: https://dx.doi.org/10.3748/wjg.v20.i16.4526